D. Hollis

发表

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

K. Owzar, M. Bertagnolli, J. Fletcher, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303

Yusuke Nakamura, Chen Jiang, Kouros Owzar, 2011, Clinical Cancer Research.

The incidence and functional consequences of RT-associated cardiac perfusion defects.

Lawrence B Marks, Salvador Borges-Neto, L. Marks, 2005, International journal of radiation oncology, biology, physics.

The effect of patient-specific factors on radiation-induced regional lung injury.

R. Jaszczak, R. Coleman, M. Anscher, 1999, International journal of radiation oncology, biology, physics.

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study.

G. Rosner, R. Schilsky, M. Ratain, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer.

L. Marks, D. Hollis, P. Hardenbergh, 2006, International journal of radiation oncology, biology, physics.

Weekly, high‐dose paclitaxel in advanced lung carcinoma

M. Ratain, J. Herndon, D. Hollis, 2003, Cancer.

Cancer and leukemia group B (CALGB) 89805

J. Tepper, M. Tempero, D. Hollis, 2003 .

A Phase II Study of Recombinant Interferon‐Gamma Following Combination Chemotherapy for Patients with Extensive Small Cell Lung Cancer

J. Herndon, D. Hollis, Mark R. Green, 1995, American journal of clinical oncology.

Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results.

R. Schilsky, A. Benson, R. Goldberg, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer.

J. Luketich, D. Sugarbaker, C. Reed, 2001, The Annals of thoracic surgery.

Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion.

D. Hollis, Sumin Zhou, S. Borges-Neto, 2003, Clinical breast cancer.

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

J. Meyerhardt, H. Nelson, C. Fuchs, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.

R. Goldberg, H. Lenz, A. Venook, 2007, Clinical colorectal cancer.

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.

R. Goldberg, H. Lenz, A. Venook, 2005, Clinical colorectal cancer.

Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

J. Tepper, R. Goldberg, D. Ryan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

G. Rosner, J. Byrd, M. Ratain, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective Evaluation of Body Surface Area as a Determinant of Paclitaxel Pharmacokinetics and Pharmacodynamics in Women with Solid Tumors

G. Rosner, M. Ratain, D. Hollis, 2004, Clinical Cancer Research.

1048 : Impact of Incidental Cardiac Irradiation on the Development of Shortness of Breath and Changes in Pulmonary Function Tests in Patients Receiving Radiation for Lung Cancer

L. Marks, D. Hollis, Sumin Zhou, 2006 .

Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

M. Anscher, L. Marks, D. Hollis, 2006, Cytokine.

The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up.

R. Jaszczak, R. Coleman, M. Anscher, 2002, International journal of radiation oncology, biology, physics.

Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803

J. Meyerhardt, R. Schilsky, C. Fuchs, 2005 .

The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803

J. Meyerhardt, R. Schilsky, C. Fuchs, 2005 .

Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with metastatic GI stromal tumors (GISTs) expressing KIT (KIT

M. Bertagnolli, J. Fletcher, G. Demetri, 2005 .

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

G. Rosner, M. Ratain, A. Venook, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)

R. Goldberg, L. Saltz, D. Hollis, 2004 .

Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803).

R. Goldberg, L. Saltz, D. Hollis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.

T. Turkington, L. Marks, D. Hollis, 2005, International journal of radiation oncology, biology, physics.

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.

J. Herndon, D. Hollis, W. Eaton, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OVX1 as a marker for early stage endometrial carcinoma

R. Bast, A. Berchuck, Yin-hua Yu, 1994 .

Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis.

L. Marks, D. Hollis, Sumin Zhou, 2007, International journal of radiation oncology, biology, physics.

Local recurrence after surgery for early stage lung cancer

L. Marks, D. Hollis, T. D’amico, 2009, Cancer.

The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests

R. Jaszczak, R. Clough, L. Marks, 2000, Cancer.

Phase II study of oral eniluracil, 5‐fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

R. Schilsky, D. Hollis, D. Niedzwiecki, 2001, Cancer.

Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101.

C. Willett, C. Fuchs, J. Tepper, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I a nd P harmacokinetic T rial o f G emcitabine i n Patients W ith H epatic o r R enal D ysfunction: C ancer a nd Leukemia G roup B 9 565

G. Rosner, M. Ratain, A. Venook, 2000 .

KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803.

J. Meyerhardt, M. Bertagnolli, S. Ogino, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer.

A. Benson, R. Goldberg, P. Enzinger, 2010 .

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.

J. Tepper, M. Tempero, D. Hollis, 2001, International journal of gastrointestinal cancer.

Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).

J. Herndon, D. Hollis, S. Luikart, 1997, American journal of clinical oncology.

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

R. Goldberg, L. Saltz, D. Hollis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regional dose response to pulmonary irradiation using a manual method.

R. Jaszczak, R. Coleman, L. Marks, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation (RT)-induced pneumonitis following tangential breast/chestwall irradiation

R. Clough, M. Bowen, M. Anscher, 2000 .

Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781.

C. Reed, J. Tepper, K. Kiel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303.

M. Bertagnolli, P. Friedman, R. Goldberg, 2011, Journal of Clinical Oncology.

Predicting RT-induced pulmonary symptoms based on the dose to the superior vs. inferior lung in patients irradiated for lung cancer

R. Jaszczak, R. Coleman, L. Marks, 2003 .

Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.

G. Rosner, R. Schilsky, M. Ratain, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of irradiated left ventricular volume on the incidence of radiation-induced cardiac perfusion changes

R. Coleman, L. Marks, D. Hollis, 2003 .

Functional consequences of radiation (RT)-induced perfusion changes in patients with left-sided breast cancer

L. Marks, D. Hollis, Sumin Zhou, 2002 .

Considerations of psychosocial illness phase in cancer survival

E. Clipp, D. Hollis, H. Cohen, 2001, Psycho-oncology.

Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.

K. Owzar, M. Ratain, M. Edelman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.

M. Caligiuri, G. Rosner, R. Schilsky, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.

M T Munley, S K Das, L B Marks, 2001, International journal of radiation oncology, biology, physics.

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression

N. Anstey, D. Hollis, D. Arnelle, 1996, The Journal of experimental medicine.

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

J. Herndon, D. Hollis, M. Green, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

D. Sugarbaker, C. Willett, C. Reed, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.

G. Rosner, M. Ratain, E. Small, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

J. Tepper, R. Goldberg, D. Hollis, 2011, Cancer.

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.

J. Tepper, M. O’connell, D. Hollis, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of number of nodes retrieved on outcome in patients with rectal cancer.

C. Compton, J. Tepper, A. Benson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

J. Abrams, D. Hollis, J. Aisner, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

D. Spiegelman, J. Meyerhardt, A. Benson, 2011, Clinical Cancer Research.

A phase I/II study of preoperative oxaliplatin (O), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901.

J. Tepper, D. Ryan, D. Hollis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

R. Schilsky, R. Goldberg, H. Hurwitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.

R. Clough, L. Marks, D. Hollis, 2002, International journal of radiation oncology, biology, physics.

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

J. Meyerhardt, A. Benson, M. Bertagnolli, 2011, Journal of the National Cancer Institute.

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

J. Meyerhardt, A. Benson, M. Bertagnolli, 2009, Clinical Cancer Research.

Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.

F. Hu, J. Meyerhardt, H. Nelson, 2007, JAMA.

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, R. Schilsky, H. Nelson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints.

R. Jaszczak, R. Coleman, R. Clough, 2000, International journal of radiation biology.

The impact of pre-radiotherapy surgery on radiation-induced lung injury.

S. Zhou, L. Marks, D. Hollis, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.

Lawrence B Marks, R. Jaszczak, R. Coleman, 2002, International journal of radiation oncology, biology, physics.

Physical and biological predictors of changes in whole-lung function following thoracic irradiation.

M T Munley, L B Marks, G C Bentel, 1997, International journal of radiation oncology, biology, physics.

Radiation-induced narrowing of the tracheobronchial tree: an in-depth analysis.

Lawrence B Marks, R. Clough, L. Marks, 2006, Lung cancer.

Dosimetric and clinical predictors for radiation-induced esophageal injury.

Lawrence B Marks, Sung-Ja Ahn, Sumin Zhou, 2005, International journal of radiation oncology, biology, physics.

Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?

R. Jaszczak, R. Coleman, M. Anscher, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relating radiation-induced regional lung injury to changes in pulmonary function tests.

R. Jaszczak, R. Coleman, M. Anscher, 2001, International journal of radiation oncology, biology, physics.

Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.

G L Rosner, G. Rosner, R. Schilsky, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

N. Kemeny, J. Herndon, H. Lenz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors associated with the development of brain metastases

D. Hollis, C. Kelsey, J. Boyd, 2010, Cancer.

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

R. Goldberg, M. Tempero, P. Enzinger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.

G. Rosner, R. Schilsky, D. Hollis, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

J. Meyerhardt, M. Bertagnolli, C. Fuchs, 2008, JAMA.

Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers

G. Riggins, J. Shoemaker, D. Hollis, 2006, Clinical Cancer Research.

Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study

G. Rosner, M. Ratain, R. Larson, 2005, Cancer Chemotherapy and Pharmacology.

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).

G. Rosner, M. Ratain, D. Hollis, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of smoking on patients with stage III colon cancer

J. Meyerhardt, A. Benson, R. Goldberg, 2010, Cancer.

Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.

K. Owzar, M. Ratain, M. Edelman, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy

M. Ratain, A. Venook, D. Hollis, 2001 .

Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results.

L. Marks, D. Hollis, G. Bentel, 2001, International journal of radiation oncology, biology, physics.

A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871

G. Rosner, M. Relling, M. Ratain, 2007, Clinical Cancer Research.

Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer?

L. Marks, D. Hollis, P. Hardenbergh, 2006 .

Is There an Increased Risk of Local Recurrence Under the Heart Block in Patients with Left‐Sided Breast Cancer?

L. Marks, D. Hollis, P. Hardenbergh, 2004, Cancer journal.

Prospective assessment of dosimetric/physiologic- based models for predicting radiation pneumonitis

J. Lebesque, L. Marks, D. Hollis, 2009 .

Prospective assessment of radiotherapy‐associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment

L. Marks, D. Hollis, P. Hardenbergh, 2007, Cancer.

Persistence of radiation (RT)-induced cardiac perfusion defects 3-5 years post RT.

D. Hollis, P. Hardenbergh, S. Borges-Neto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).

R. Schilsky, R. Goldberg, G. Abou-Alfa, 2010, The oncologist.

Pharmacokinetic (PK) and phase I study of sorafenib (S) for solid tumors and hematologic malignancies in patients with hepatic or renal dysfunction (HD or RD): CALGB 60301

K. Owzar, M. Ratain, G. Abou-Alfa, 2007 .

A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB

R. Schilsky, H. McLeod, R. Goldberg, 2007 .

Association between RT-induced changes in lung tissue density and global lung function.

L. Marks, D. Hollis, C. Kelsey, 2008, International journal of radiation oncology, biology, physics.

Regional lung density changes after radiation therapy for tumors in and around thorax.

Lawrence B Marks, Jinli Ma, Sumin Zhou, 2010, International journal of radiation oncology, biology, physics.

Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma

C. Fuchs, J. Tepper, R. Goldberg, 2005 .

Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581).

C. Compton, D. Kerr, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can W e P redict R adiation-Induce d C hanges i n P ulmonary Function B ased o n t he S um o f P redicted R egional Dysfunction?

R. Jaszczak, R. Coleman, M. Anscher, 2001 .

A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

R. Schilsky, R. Goldberg, A. Venook, 2009, Annals of Surgical Oncology.

A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

R. Schilsky, R. Goldberg, A. Venook, 2007, Annals of Surgical Oncology.

"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.

L. Marks, D. Hollis, T. D’amico, 2005, International journal of radiation oncology, biology, physics.

The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.

L. Marks, D. Hollis, Sumin Zhou, 2007, International journal of radiation oncology, biology, physics.

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure

L. Marks, D. Hollis, C. Kelsey, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).

G. Rosner, R. Schilsky, M. Ratain, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Is the Development of Symptomatic Radiation Pneumonitis Associated With an Inherent Increased Sensitivity of Lung to Radiation-Induced Injury?

L. Marks, D. Hollis, R. Folz, 2007 .

Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity.

R. Clough, L. Marks, D. Hollis, 2004, International journal of radiation oncology, biology, physics.

Impact of age and comorbidities on treatment effect, tolerance, and toxicity in metastatic colorectal cancer (mCRC) patients treated on CALGB 80203.

J. Meyerhardt, R. Goldberg, A. Venook, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803

J. Meyerhardt, C. Fuchs, L. Saltz, 2008 .

A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904).

M. Tempero, D. Hollis, D. Niedzwiecki, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603

R. Goldberg, T. Bekaii-Saab, D. Hollis, 2008 .

Serum levels of HER‐2 neu (C‐erbB‐2) correlate with overexpression of p185neu in human ovarian cancer

R. Bast, A. Berchuck, R. Whitaker, 1993, Cancer.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.

J. Lebesque, L. Marks, D. Hollis, 2007, International journal of radiation oncology, biology, physics.

A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871

G. Rosner, M. Relling, M. Ratain, 2007, Clinical Cancer Research.